Table: Garna Biosciences -Q1 group results

Carna Biosciences

10/05/2023 07:30

May 10 (Reuters)- 
             Garna Biosciences Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to   
                Mar 31, 2023        Mar 31, 2022       Dec 31, 2023  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            226 mln             554 mln           902 mln     
                 (-59.1 pct)        (+139.8 pct)       (-34.9 pct)   
  Operating     loss 505 mln            1 mln           loss 1.89    
  Recurring     loss 513 mln            4 mln           loss 1.91    
  Net           loss 519 mln         loss 15 mln        loss 1.94    
  EPS          loss 32.78 yen       loss 1.12 yen    loss 125.25 yen 
  Ann Div                                NIL               NIL       
  -Q2 div                                NIL               NIL       
  -Q4 div                                NIL               NIL       
  
  NOTE - Garna Biosciences Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T